Rukkumani Rajagopalan - Publications, H-index & Citations

Rukkumani Rajagopalan

School of Life Sciences

37H指数

184论文数

4.4K被引数

收录论文 40

发表时间

Exploration of mechanism of anticancer potential of fisetin nanoformulations: nanotized fisetin/fisetin loaded polymannose nanoparticles in the treatment of triple negative breast carcinoma 探索 fisetin 纳米制剂抗癌潜力的机制：纳米化 fisetin/fisetin 负载的多聚甘露糖纳米颗粒在治疗三阴性乳腺癌中的应用

3 Biotech

IF2.9

2025-07-24

PREAI

Neena Yadav; Saswat Kumar Mohanty; Sathyapriya Chandramohan; V. K. Archana; Kitlangki Suchiang; Rukkumani Rajagopalan

Biogenic synthesis of zinc oxide nanoparticles using leaf extract of Oxalis stricta and its effect on colon cancer: an in vitro and in silico approach 利用Oxalis stricta叶提取物生物合成氧化锌纳米颗粒及其对结肠癌的影响：体外与计算机模拟研究

BioMetals

IF3.6

2025-07-04

PREAI

Sathyapriya Chandramohan; Anjali Suresh Nair; Richa Das; Suhail Ahmad Bhat; Guguloth Sai Krishna; Neena Yadav; V. K. Archana; Rukkumani Rajagopalan

Multifaceted investigation of zinc oxide nanoparticles synthesized from Vernonia elaeagnifolia leaf extract: Characterization, antibacterial, antioxidant, cytotoxicity, and DNA binding activities 从Vernonia elaeagnifolia叶提取物合成的氧化锌纳米颗粒的多方面研究：表征、抗菌、抗氧化、细胞毒性和DNA结合活性

inorganic chemistry

IF5.4

2025-07-01

PREAI

Chandramohan, Sathyapriya; Ramalingam, Priya; Krishna, Guguloth Sai; Manikandan, E.; Rajagopalan, Rukkumani

Cytotoxic potential of an indole-conjugated Oleanolic acid analogue: suppression of NSCLC proliferation through modulation of mitochondrial apoptotic dynamics 吲哚偶联的齐墩果酸类似物的细胞毒性潜力：通过调节线粒体凋亡动力学抑制NSCLC增殖

TOXICOLOGY MECHANISMS AND METHODS

IF2.7

2025-03-25

PREAI

Srividya Subramanian; Sankar Pajaniradje; Suhail Ahmad Bhat; Sathyapriya Chandramohan; Parthiban Anaikutti; Rukkumani Rajagopalan

Revolutionizing fisetin's anticancer potential: nanotechnology and computational approaches unveil enhanced CT-DNA interactions and bioavailability of nano-fisetin 革命性开发槲皮素的抗癌潜力：纳米技术和计算方法揭示了纳米槲皮素增强的CT-DNA相互作用及其生物利用度

NEW JOURNAL OF CHEMISTRY

IF2.5

2025-01-01

PREAI

Yadav, Neena; Tufail, Aisha; Rajagopalan, Rukkumani; Dubey, Amit

An in-vitro study of active targeting & anti-cancer effect of folic acid conjugated chitosan encapsulated indole curcumin analogue nanoparticles

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-12-01

PREAI

Dutta, Dipranil; Pajaniradje, Sankar; Nair, Anjali Suresh; Chandramohan, Sathyapriya; Bhat, Suhail Ahmad; Manikandan, E.; Rajagopalan, Rukkumani

A review on biomaterials-based scaffold: An emerging tool for bone tissue engineering

MATERIALS TODAY COMMUNICATIONS

IF4.5

2023-03-01

PREAI

Francis, Arul Prakash; Augustus, Akshaya Rani; Chandramohan, Sathyapriya; Bhat, Suhail Ahmad; Priya, Veeraraghavan Vishnu; Rajagopalan, Rukkumani

Cudetaxestat, a differentiated phase 2-ready investigational treatment for idiopathic pulmonary fibrosis

EUROPEAN RESPIRATORY JOURNAL

IF21

2022-12-01

PREAI

Elmankabadi, B.; Ibrahim, P.; Wong, C.; Rajagopalan, R.; Xu, X.; Yu, W.

Implications of Three-Dimensional Cell Culture in Cancer Therapeutic Research

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-12

OAAI

Poornima, Kolluri; Francis, Arul Prakash; Hoda, Muddasarul; Eladl, Mohamed Ahmed; Subramanian, Srividya; Veeraraghavan, Vishnu Priya; El-Sherbiny, Mohamed; Asseri, Saad Mohamed; Hussamuldin, Abdulrahman Bashir Ahmed; Surapaneni, Krishna Mohan; Mony, Ullas; Rajagopalan, Rukkumani

Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-10-01

PREAI

Sufi, Shamim Akhtar; Hoda, Muddasarul; Pajaniradje, Sankar; Mukherjee, Victor; Coumar, Selvaraj Mohane; Rajagopalan, Rukkumani

Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases

ANTIOXIDANTS & REDOX SIGNALING

IF6.1

2019-02-10

PREAI

Sufi, Shamim Akhtar; Pajaniradje, Sankar; Mukherjee, Victor; Rajagopalan, Rukkumani

In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2017-01-01

PREAI

Sufi, Shamim Akhtar; Adigopula, Lakshmi Narayana; Syed, Safiulla Basha; Mukherjee, Victor; Coumar, Mohane S.; Rao, H. Surya Prakash; Rajagopalan, Rukkumani

BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway-A comparative study with curcumin

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2015-08-01

PREAI

Mohankumar, Kumaravel; Sridharan, Subhashree; Pajaniradje, Sankar; Singh, Vivek Kumar; Ronsard, Larance; Banerjea, Akhil C.; Somasundaram, Dinesh Babu; Coumar, Mohane Selvaraj; Periyasamy, Latha; Rajagopalan, Rukkumani

Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways

CELLULAR ONCOLOGY

IF4.8

2014-12-01

PREAI

Mohankumar, Kumaravel; Pajaniradje, Sankar; Sridharan, Subhashree; Singh, Vivek Kumar; Ronsard, Larance; Banerjea, Akhil C.; Selvanesan, Benson Chellakkan; Coumar, Mohane Selvaraj; Periyasamy, Latha; Rajagopalan, Rukkumani

KINASE SELECTIVITY PROFILES OF NINTEDANIB AND IMATINIB

THORAX

IF7.7

2014-11-10

OAAI

Rajagopalan, R.; Nicholas, J.; Misialek, S.; Buckman, S.; Seiwert, S.

A RISK STRATIFICATION TOOL FOR SCREENING FOR DIABETIC RETINOPATHY AMONG TYPE 2 DIABETIC PATIENTS

VALUE IN HEALTH

IF6

2014-05-01

OAAI

Sun, Y.; Paul, P.; Tan, N.; Rajagopalan, R.; Lew, Y.; Heng, B. H.

CHARACTERIZATION OF NOVEL, HIGHLY POTENT NS5A INHIBITORS WITH QD DOSING POTENTIAL AND ROBUST ACTIVITY IN AN HCV CHIMERIC ANIMAL MODEL

JOURNAL OF HEPATOLOGY

IF33

2011-03-01

PREAI

Nicholas, J. B.; Buckman, B. O.; Serebryany, V.; Schaefer, C. J.; Kossen, K.; Ruhrmund, D.; Hooi, L.; Aleskovski, N.; Arfsten, A.; Lim, S. R.; Pan, L.; Huang, L.; Rajagopalan, R.; Misialek, S.; Seiwert, S.

NOVEL, POTENT, PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITORS WITH A HIGH BARRIER TO RESISTANCE

JOURNAL OF HEPATOLOGY

IF33

2011-03-01

OAAI

Buckman, B. O.; Kossen, K.; Nicholas, J. B.; Serebryany, V.; Ruhrmund, D.; Rajagopalan, R.; Misialek, S.; Hooi, L.; Aleskovski, N.; Pan, L.; Huang, L.; Schaefer, C. J.; Rajyaguru, S.; Le Pogam, S.; Najera, I.; Klumpp, K.; Seiwert, S.

COMBINATION OF THE NS3/4A PROTEASE INHIBITOR ITMN-191 WITH THE ALLOSTERIC NS5B POLYMERASE INHIBITOR ITMN-8020 ENHANCES REPLICON CLEARANCE AND REDUCES THE EMERGENCE OF DRUG RESISTANT VARIANTS

JOURNAL OF HEPATOLOGY

IF33

2009-04-01

OAAI

Tan, H.; Wang, G.; Moy, C.; Kossen, K.; Rajagopalan, R.; Misialek, S.; Ruhrmund, D.; Hooi, L.; Snarskaya, N.; Stoycheva, A.; Buckman, B.; Seiwert, S.; Beigelman, L.

DISCOVERY OF POTENT, BIOAVAILABLE HCV NS3/4A INHIBITORS THAT DISPLAY UNIMPAIRED ACTIVITY AGAINST AN NS3 SEQUENCE VARIANT ASSOCIATED WITH RESISTANCE TO LINEAR TETRAPEPTIDES AND MACROCYCLIC INHIBITORS

JOURNAL OF HEPATOLOGY

IF33

2009-04-01

OAAI

Buckman, B.; Kossen, K.; Ruhrmund, D.; Rajagopalan, R.; Stevens, S.; Hooi, L.; Snarskaya, L.; Wang, T.; Hong, J.; Lim, S.; Pan, L.; Huang, L.; Stoycheva, N.; Beigelman, L.; Seiwert, S.

研究方向